Key learning objectives
- Evaluate the key contributing factors for the development of therapeutic inertia – consider personal barriers
- Review important factors to consider when selecting an injectable incretin therapy
- Identify the patient education needs and support requirements for the initiation of injectable incretin therapies
- Apply knowledge in case study discussions
Speakers:
- Louise Dodd, Medical education associate, Lilly
- Dr Yassir Javaid, GPWSi, Northampton
Your contact details will be shared with Lilly.